Alison Moe
Physician Assistant · Atlanta, GANPI 1417227448
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $266,067 of the $409,952 with a category attached, or 64.9%. AbbVie accounts for 78.3% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $205,153, 7.3 times the $28,188 reported in 2021. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,012 payments — averaging $405.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$321K
- Madrigal Pharmaceuticals$79K
- Genentech USA, Inc.$3K
- Sanofi$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$757
- Celltrion USA Inc.$645
- plus $4K from 25 others
What the payments were for
- Consulting fees$13,5293%
- Speaking & faculty fees$266,06765%
- Travel & lodging$105,85726%
- Food & beverage$24,4006%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 583 | $321,026 |
| Madrigal Pharmaceuticals | 181 | $79,227 |
| Genentech USA, Inc. | 6 | $2,969 |
| Sanofi | 19 | $1,493 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $757 |
| Celltrion USA Inc. | 10 | $645 |
| Johnson & Johnson(2 entities) | 31 | $590 |
| Regeneron Healthcare Solutions, Inc. | 21 | $457 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $418 |
| QOL Medical, LLC | 14 | $383 |
| Ardelyx, Inc. | 15 | $280 |
| Pfizer | 17 | $259 |
| GSK | 1 | $250 |
| Phathom Pharmaceuticals, Inc. | 20 | $245 |
| Bristol Myers Squibb | 13 | $198 |
| Medtronic | 4 | $150 |
| Lilly USA, LLC | 6 | $134 |
| Boehringer Ingelheim | 2 | $53 |
| Boston Scientific | 2 | $52 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| Vivus LLC | 2 | $47 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Ironwood Pharmaceuticals, Inc | 2 | $42 |
| Organon | 2 | $41 |
| Orphalan Inc | 1 | $29 |
| Amgen | 1 | $25 |
| Merck | 1 | $25 |
| Novo Nordisk | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$409,952 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sandostatin Lar DepotOctreotide Acetate,mi-Spheres | 12 | $53,755 |
| CreonLipase/Protease/Amylase | 13 | $40,051 |
| IbsrelaTenapanor Hcl | 16 | $28,597 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 52 | $8,955 |
| Sucralfate | 26 | $5,112 |
| Pantoprazole Sodium | 225 | $1,651 |
| Colestipol Hcl | 30 | $1,640 |
| Dicyclomine Hcl | 30 | $618 |
| Famotidine | 112 | $557 |
| Esomeprazole Magnesium | 13 | $523 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 22 | $363 |
| Ondansetron OdtOndansetron | 14 | $305 |
| Metoclopramide Hcl | 13 | $123 |
| Ondansetron Hcl | 16 | $117 |
| Omeprazole | 13 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $321,026 | $40,05113 claims |
| Ardelyx, Inc.Ibsrela | $280 | $28,59716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Maggie SchreckAtlanta$389K
- Jaime AckermanAtlanta$84K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
- Laura GillespieAtlanta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.